Breaking News

Macfarlan Smith Annan Facility Marked for Closure  

Proposal follows a review of its manufacturing capacity relative to customer needs and market trends.

Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility. 

Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product portfolio. 

As an outcome of this review, Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility. 

Niek Stapel, Veranova’s CEO said “Every effort has been made to avoid proposing the closure of the plant. This was a difficult decision to make which in no way reflects the performance or commitment of our colleagues at Annan.”

The proposed closure is subject to statutory consultation requirements under UK law.

Veranova is involved in process development and manufacturing of APIs wth a focus on speciality and complex products. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters